Inhibition of sorbitol dehydrogenase by nucleosides and nucleotides

• Sheep liver sorbitol dehydrogenase is inhibited by nucleosides and corresponding nucleoside phosphates.
• The reversible inhibition patterns reflect formation of enzyme–coenzyme inhibitor ternary complexes.
• The 2′-position of the ribose moiety of the inhibitor structures is important for inhibitor potency.
• Sorbitol was docked into the structure of the sheep SDH-NAD+ complex (PMDB ID code PM 0078068).

Sorbitol dehydrogenase inhibitors have been found to prevent, or alleviate, various secondary complications of diabetes mellitus. In the present study, the effects of nucleosides and nucleotides on the rate of sorbitol oxidation catalyzed by the sheep liver enzyme were studied by steady-state kinetics at pH 7.4. Various such compounds, including ATP and the 2′-deoxy-analogues of ATP, ADP and AMP, reversibly inhibit enzyme activity by formation of enzyme–coenzyme-inhibitor ternary complexes. In each case, no deviations from linearity were seen in the double-reciprocal plots using sorbitol or NAD+ as the varied substrate and there was a linear relationship between inhibitor concentration and the observed inhibitory effects. Sorbitol was docked into a model of the sheep SDH-NAD+ complex based upon the structure of the human SDH-NAD+ holoenzyme. The resulting structure of the ternary complex of sheep SDH, NAD+ and sorbitol (PMDB ID code PM 0078068) shows that the reactive C-2 hydroxyl group of sorbitol is oriented toward the 4′-position of the nicotinamide moiety of the coenzyme, and that the adjacent primary hydroxyl group of sorbitol interacts with the catalytic zinc. The results indicate that the ribose moiety of the inhibitor structures is an important determinant for the observed effects. Specifically, the 2′-position of the ribose ring exerts an effect with respect to inhibitor potency.